141 related articles for article (PubMed ID: 16013917)
1. Weight gain and antipsychotics.
Mackin P
J Clin Psychiatry; 2005 Jul; 66(7):950-1; author reply 951. PubMed ID: 16013917
[No Abstract] [Full Text] [Related]
2. Reversal of antipsychotic-induced weight gain during quetiapine treatment.
Koponen H; Larmo I
Int Clin Psychopharmacol; 2003 Nov; 18(6):355-6. PubMed ID: 14571156
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine-induced weight gain and escitalopram.
Holzer L; Paiva G; Halfon O
Am J Psychiatry; 2005 Jan; 162(1):192-3. PubMed ID: 15625223
[No Abstract] [Full Text] [Related]
4. Differing tolerability profiles among atypical antipsychotics.
Hellewell JS; Haddad PM
Am J Psychiatry; 2001 Mar; 158(3):501-2. PubMed ID: 11230007
[No Abstract] [Full Text] [Related]
5. Second-generation antipsychotics cause weight gain in youths.
Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
[No Abstract] [Full Text] [Related]
6. Substantial weight gain associated with severe carbohydrate craving in a patient receiving quetiapine.
Kluge M; Dietzel J
Psychiatry Clin Neurosci; 2013 Apr; 67(3):189-90. PubMed ID: 23581871
[No Abstract] [Full Text] [Related]
7. FDA advisers wary of expanding quetiapine use: clinicians air concerns about metabolic effects, tardive dyskinesia.
Traynor K
Am J Health Syst Pharm; 2009 May; 66(10):880, 882. PubMed ID: 19420301
[No Abstract] [Full Text] [Related]
8. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
9. Review of atypical antipsychotics and weight gain.
Sussman N
J Clin Psychiatry; 2001; 62 Suppl 23():5-12. PubMed ID: 11603886
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
11. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
Bond DJ; Kauer-Sant'Anna M; Lam RW; Yatham LN
J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
[TBL] [Abstract][Full Text] [Related]
12. Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
Kelly DL; Kreyenbuhl J; Love RC; Van-Duong Q; Conley RR
J Clin Psychiatry; 2003 Sep; 64(9):1133-4. PubMed ID: 14628994
[No Abstract] [Full Text] [Related]
13. Weight gain induced with olanzapine in adolescent.
Graovac M; Ružić K; Rebić J; Dadić-Hero E; Kaštelan A; Frančišković T
Psychiatr Danub; 2011 Mar; 23(1):101-4. PubMed ID: 21448109
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and atypical neuroleptics.
Geller WK; MacFadden W
Am J Psychiatry; 2003 Feb; 160(2):388; author reply 389. PubMed ID: 12562601
[No Abstract] [Full Text] [Related]
15. Long-term remission of schizophrenia in an adolescent treated with quetiapine.
Hayden F
J Child Adolesc Psychopharmacol; 2001; 11(3):289-93. PubMed ID: 11642479
[TBL] [Abstract][Full Text] [Related]
16. [The appearance of metabolic syndrome in treatment with atypical antipsychotics].
Mosolov SN; Kabanov SO
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):62-9. PubMed ID: 14681970
[No Abstract] [Full Text] [Related]
17. The value of atypical antipsychotics in the treatment of schizophrenia.
Jessen LM
Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
[No Abstract] [Full Text] [Related]
18. The pharmacology of weight gain with antipsychotics.
Casey DE; Zorn SH
J Clin Psychiatry; 2001; 62 Suppl 7():4-10. PubMed ID: 11346195
[TBL] [Abstract][Full Text] [Related]
19. The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Citrome L; Volavka J
Postgrad Med; 2004 Oct; 116(4):49-51, 55-9, 63. PubMed ID: 15510593
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
